Search PubMed⌕ Search

Biomedical subjects

N Crossley

Publications and source records attributed to N Crossley.

11 recordsLinked to original sources
PubMed2001

'Patient' voices, social movements and the habitus; how psychiatric survivors 'speak out'.

What is the 'voice' of the mental health 'user'? This paper seeks to address this question through the presentation of a detailed comparative analysis of two anthologies written by people living with mental 'illness' in the 1950s and 1990s. Using a narrative-style qualitative analysis, the structure and content of the two anthologies is explored. The analysis illustrates the way in which the 'voice' of the mental patient in the 1950s was very different to that of today. The paper then aims to provide a theoretical explanation that accounts for this transformation of voice. Appropriating theoretical concepts from phenomenology and sociology, in particular, Bourdieu's concept of 'habitus', the paper explores the way in which the 'personal' voice of the mental patient is formulated in dialogical relation to wider public and collective movements. These, in turn, connect to broader transformations in the social, economic and health 'fields'.

Attitude to Health↗
PubMed1999

Fish, field, habitus and madness: the first wave mental health users movement in Great Britain.

This paper traces and explains the emergence of the mental health users movement in Great Britain, focusing specifically upon the formation of the Mental Patients Union in the early 1970s. The analysis presented in the paper draws, to some extent, from conventional movement theory. In addition, however, it draws from the work of Pierre Bourdieu. This represents an innovation in movement analysis and the necessity of this innovation is argued for in an early section of the paper.

History, 20th Century↗
PubMed1998

R. D. Laing and the British anti-psychiatry movement: a socio-historical analysis.

In this paper I present a socio historical analysis of the rise of the British anti-psychiatry movement. I have three aims. Firstly, to establish what anti-psychiatry was. Secondly, to investigate and explain its emergence. Thirdly, to consider its relationship to other "new social movements". This analysis is important because criticism and opposition, such as that of the anti-psychiatrists, has been an integral element of the psychiatric field since its earliest developments but has seldom been studied by social scientists, particularly in relation to the post-war period. Power and dominant discourses have been the key focus of analysis, to the detriment of a proper consideration of resistance and counter-discourses. This omission is problematic and should be corrected as social movements introduce plurality, dynamism and the potential for change into the psychiatric field, thus contributing quite centrally to its constitution. Anti-psychiatry is, of course, only one of many movements which require analysis in this connection but it was an important movement and we must begin somewhere. In addition, an analysis of anti-psychiatry serves as an important case study for the sociology of social movements, and particularly for the concern with "new social movements" (NSMs). An analysis of it necessarily makes a contribution to our understanding of NSMs.

History, 20th Century↗
PubMedDate not supplied

Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels.

Cyclosporine (CyA) monitoring with postabsorptive levels can predict the risk of an acute rejection episode (ARE). Large doses of CyA are needed to obtain adequate drug exposure. The impact of this strategy on renal function, especially in patients with delayed graft function (DGF), is unknown. We report our experience comparing C3 (3-hour postdose) monitoring with a historical series of cadaveric renal transplants. Sixty-three consecutive patients who received cadaveric renal transplants were followed for 1 year. Group A (historical n = 31) patients received 6 mg/kg/d CyA with the dose adjusted according to the trough level (target, 250-350 ng/mL), group B (study n = 32) received 10 mg/kg/d CyA with dose adjustments based upon C3 (target, 1100-1500 ng/mL). All patients received cyclosporine prednisone and a third agents. The general characteristics of the donors and recipients were comparable. The incidence of biopsy-proven ARE at 1 year in group A was 42% and 19% in group B (P <.05). Patients achieving C3 levels >1000 ng/mL at 1 week displayed significantly lower ARE rates (8% vs 50%; P <.05). The rate of DGF was similar in both groups, but the duration was longer in group B (15 vs 21 days, P <.05). The serum creatinine (SCr) level was significantly higher in group B at 3 months (1.47 mg/dL group A vs 1.76 mg/dL group B; P <.05). Patients in group B with DGF showed significantly higher SCr values at 1 year (1.18mg% vs 2.03 mg%; P <.05). C3 level monitoring of CyA yields excellent results in terms of decreased ARE, but an increased SCR was observed among patients with DGF.

Creatinine↗